Sen. Burr’s Parting Gifts For US FDA Include ‘Platform’ Pathway
• By Michael McCaughan
Sen. Burr's legislative work could help give birth to a regulatory pathway for gene therapy vectors and other platform technologies. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
